A further study found that administration of TNF in a generalised model of brain injury had a reduction in SD amplitude, possibly suggesting that TNF, particularly via its receptor TNFR2, has a neuroprotective effect to limit SD during injured states [18]. The gene discussed is TNFRSF1B; the disease is injury.